ABVCNasdaq United States
Market cap
$27.085 M
$1.02 +0.00%
Close of 7 Aug 2026
Revenue
$509.6K
#3555 by revenue
Earnings
-$7.91M
Loss-making
Shares outstanding
25,440,407
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Abvc Biopharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.